Skip to content
Lower risk Drug recall · FDA · Published March 28, 2024

Teva Isotretinoin Capsules 40mg Recall: Stability Issue

Teva recalls 40mg Isotretretinoin capsules due to potential stability issues affecting drug potency. Learn about affected lots and what to do.

🇺🇸 FDA recall #D-0439-2024DrugTeva ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA, Inc400 Interpace Pkwy Bldg A · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Teva is recalling 40mg Isotretinoin capsules that may have stability issues. This could affect the drug's potency, but the recall does not indicate immediate safety risks to users. Read more at govinfonow.com/recall/32753-teva-isotretinoin-capsules-40mg-recall-stability-issue.

Source Summary by GovInfoNow · govinfonow.com/recall/32753-teva-isotretinoin-capsules-40mg-recall-stability-issue · Updated August 17, 2026 · FDA enforcement record: FDA #D-0439-2024

Cite this page

“Teva Isotretinoin Capsules 40mg Recall: Stability Issue.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32753-teva-isotretinoin-capsules-40mg-recall-stability-issue. Based on FDA recall #D-0439-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0439-2024%22&limit=1).

The FDA announced on March 28, 2024, that Teva Pharmaceuticals USA, Inc. is recalling Isotretinoin Capsules, USP 40mg due to assay results exceeding specification limits. The agency issued recall number D-0439-2024 for the voluntary Class II action.

How to tell if you have it

  • Brand: Teva
  • Product: Isotretinoin Capsules, USP 40mg
  • Packaging: 30-count 3x10 blister packs per carton
  • Blister Pack NDC: 0591-2436-45
  • Carton NDC: 0591-2436-15
  • Lot #: 100044259
  • Expiration Date: 06/30/2025
  • Quantity: 5,304 cartons

The hazard

The recall addresses a stability result for assay found to be above the specification limit at three months. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Teva Pharmaceuticals USA, Inc. has 59 other recalls on record since April 2, 2012. Other recent recalls of similar products include Teva recalling traZODone 50mg tablets on August 24, 2026, and Teva Octreotide Acetate 30mg Kit on April 24, 2026. Cipla issued recalls for Nilotinib 200mg Capsules and Phytonadione Injectable Emulsion in February and October 2025 respectively due to stability issues.

How to tell if you have this one

Check for blister packs labeled NDC 0591-2436-45 and cartons with NDC 0591-2436-15. The lot number 100044259 and expiration date of 06/30/2025 are also key identifiers.

  • Brand
    Teva
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the blister pack NDC 0591-2436-45 and carton NDC 0591-2436-15 with lot number 100044259.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

1. Firm started the recall: Mar 28, 202412. FDA classified it Class II: Apr 8, 202423. Published in FDA’s Enforcement Report: Apr 17, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Teva recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0439-2024 (March 28, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0439-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA